New combo pill for diabetes and high cholesterol
Part of Hormones & metabolism clinical trials.
This trial tests a new combination pill for people with type 2 diabetes and high cholesterol who are already on metformin. It aims to see if the new drug helps control both blood sugar and cholesterol better than current treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 80 years old and live in South Korea.
- You have both type 2 diabetes and high cholesterol (dyslipidemia).
- You take at least 1000 mg of metformin daily, either alone or with another diabetes pill.
- Your most recent HbA1c (average blood sugar) is between 7.0% and 10.5%.
- Your fasting blood sugar is 270 mg/dL or lower.
- Your fasting LDL (bad cholesterol) is between 100 and 250 mg/dL, and your triglycerides are 400 mg/dL or lower.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
This trial tests an investigational drug called HDM1005 for people with type 2 diabetes whose blood sugar is still high despite taking metformin (with or without another diabetes pill called an SGLT2 inhibitor). The goal is to see if the new drug can better lower blood sugar levels.
This trial compares adding a new pill (cofrogliptin) to increasing your current metformin dose, for people whose blood sugar is still too high despite taking an SGLT2 inhibitor and a low dose of metformin. The goal is to see which option works better and is safer.
This trial tests whether combining two new medications (DWP16001 and DWC202518) works better than taking either one alone for controlling type 2 diabetes. You'll be randomly assigned to one of three groups and monitored for safety and how well your blood sugar is controlled.
This trial tests how a new combination of drugs (BR3006A, BR3006B, and BR3006C) is absorbed and processed by the body when taken together, compared to a single tablet (BR3006). It is for healthy adults to understand the safety and behavior of the medication.
Hear when a new Dyslipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.